# CEUS Evaluation of Hydrocephalus in Neonates and Infants

> **NCT06693752** · PHASE2 · RECRUITING · sponsor: **Children's Hospital of Philadelphia** · enrollment: 20 (estimated)

## Conditions studied

- Hydrocephalus in Infants
- Hydrocephalus Acquired

## Interventions

- **DRUG:** Sulfur Hexafluoride Lipid Type A Microspheres 25 mg Injection Powder for Suspension [LUMASON]

## Key facts

- **NCT ID:** NCT06693752
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-05
- **Primary completion:** 2026-08-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06693752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06693752, "CEUS Evaluation of Hydrocephalus in Neonates and Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06693752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*